Edibles, Medical, Concentrates, Oh My! The Best Brands In Each Weed Category

Most smokers remember a day when they were happy to get whatever strain of weed they could find — but now that marijuana is decriminalized across much of the U.S. and legalized medically and/or recreationally in more than half of all states, stoners can afford to be a bit more discriminating. These days, cannabis lovers can enjoy a large and diverse selection of brands and products, from traditional flower to vape products, concentrates, capsules, edibles and more.

If you don’t want to waste your time trying lower-quality weed products, you don’t have to. Read on for recommendations for the best of the best brands in each product category.

medical weedMedical

Since medicinal marijuana has been legalized in more states than recreational weed, there has been more time for medical cannabis brands to grow and develop. While medical marijuana products vary in type — you can find medical bud and pre-rolls as well as edibles, vapes and more — we are separating this category because brands here have claims about their products that other weed brands might not. Specifically, medical cannabis tends to boast a higher quality of product and more controlled experiences, such as less euphoria and paranoia and more pain relief or relaxation. Some medical marijuana brands target specific medical ailments, like menstrual discomfort or arthritis, but here are the best general medical marijuana brands on the market:

  • Nature’s Medicines. Starting as a dispensary chain and now producing a line of unique, high-quality strains and concentrates, Nature’s Medicines is gaining national attention for its efficacy.
  • Trulieve. Offering flower, vape cartridges and a number of concentrates, Trulieve is an exceedingly accessible medical marijuana brand that places emphasis on safety.
  • KIND Concentrates. As the name suggests, KIND Concentrates specializes in concentrates, specifically capsules, vape pens, RSOs and the like, with high percentages of THC.

Flower

To those new to cannabis culture, “flower” (also called bud and nug) is the portion of the marijuana plant that contains the highest percentage of cannabinoids that create the mind and body high stoners (and other marijuana users) seek. While flower is ground up and refined in chemical processes to produce edibles, concentrates and other weed products, you can still purchase flower on its own to smoke in joints, pipes and bongs or to generate your own cannabis creations. However, flower can vary greatly in quality, so until you get a feel for finding the best buds in your local dispensary, you should stick to ordering from these brands:

  • Caviar Gold. Marketed as the strongest weed in America, Caviar Gold offers four types of flower, all of them considerably higher quality than anything else in the market.
  • Omaha Farms. Recently purchased by marijuana giant MedMen, Omaha Farms is wildly popular for its flower Salad Bowls, which should be widely available soon.

Edibles

Humans have long experimented with baking and cooking cannabis into all forms of food, with the result that the candies, baked goods, crackers and other treats now available tend to be exceptionally refined recipes that taste as good (or better) as anything you can find in a regular grocery store. The world of edibles is huge and truly deserves a post all to itself — after all, how do you compare a chocolate bar with beef jerky? Still, experts agree that you can’t go wrong with the following edible brands:

  • Kiva. It’s hard to mention edibles without bringing up Kiva, which was the first widely available edible brand that used professionally trained chefs and chocolatiers to produce high-quality treats.
  • Baked Bros. Baked Bros essentially set the industry standard for infused gummies back in 2014 when their Sour Kush Kids won the Cannabis Cup, and they continue to offer the best worms, rings, bears and more on the market.
  • LOL Edibles. Specializing in reimagining popular snacks as weedy treats, LOL Edibles offers pitch-perfect THC versions of Froot Loops, Cap’n Crunch, Cheetos and more.
  • Kush Nuts. For potheads without a sweet tooth, Kush Nuts produces savory nut mixes seasoned with THC-infused oils. They look and feel fancy, but they’ll definitely get you high.

Vapes

Even amidst the concern about a vape-related lung illness, vaping remains one of the most popular ways to use cannabis. Vapes tend to offer a concentrated hit of CBD and/or THC that creates an immediate effect; plus, they are small and tend to produce less odor than traditional smoking, making them discreet for stoners on the go. Yet, it is becoming ever more obvious that quality is imperative in vape tools and products, so you should stick to these best vape brands:

  • Dosist. Setting aside the vape juice for a moment, it should be noted that Dosist produces some of the most attractive vape pens of all time. Perhaps this is why Dosist is becoming one of the fastest growing marijuana businesses in the country.
  • Willie’s Reserve. In truth, Willie Nelson offers all kinds of stuff in his line of marijuana products, but his vape cartridges are the cream of the crop.
  • Roots. Roots offers another stunningly beautiful vape pen as well as premium vape oil extracted from the highest quality cannabis plants.

You don’t have to settle for whatever weed you can scrounge up from the shady neighborhood dealer. If you try any one of the above brands, you won’t ever be tempted to go back to low-quality skunk; you’ll develop the refined marijuana palette that you deserve.

 

 

MedMen Announces Completion Of Sale Of Two Properties To Cannabis REIT

CALIFORNIA: MedMen Enterprises announced that it has completed the sale of two properties to Treehouse Real Estate Investment Trust, Inc. with gross proceeds of approximately $33.5 million and net proceeds of approximately $30.6 million after repayment of debt.

medmen

“This is our second transaction with Treehouse and we’ve now freed up nearly $49 million to invest directly into our growth initiatives,” said Adam Bierman, MedMen’s chief executive officer and co-founder.

The properties are comprised of a retail storefront in Las Vegas, Nevada and a cultivation, manufacturing and production facility in Desert Hot Springs, California.

The Las Vegas property is located on Highland Drive near the Las Vegas Strip. The store is scheduled to open later in calendar year 2019. The property is 10,417 square feet and will feature a 30’x70’ LED glass store front. It will be the Company’s largest store to date. Las Vegas ranks as one of the world’s most visited tourist destinations, with more than 42 million visitors in 2018, according to Statista. Nevada legalized adult-use sales in 2017 and revenue for calendar year 2019 are projected to exceed $600 million according to Cowen, Inc. MedMen currently operates three stores in Las Vegas.

The Desert Hot Springs, California, property is comprised of an approximately 45,000 square foot, state-of-the-art Dutch greenhouse offering complete climate control and including manufacturing and production capabilities. The facility recently received its certificate of occupancy and is expected to commence producing the Company’s in-house brands later this year.

 

MedMen’s New Commercial Chronicles The History of American Cannabis From Counterculture To Just Culture

MedMen’s The New Normal Taps Acclaimed Filmmaker Spike Jonze and Actor/Activist Jesse Williams to Normalize Cannabis

CALIFORNIA: MedMen Enterprises rewrote history yesterday with the debut of a disruptive new commercial that chronicles the American history of cannabis. Supported by the most expansive integrated marketing campaign the company has executed to date, The New Normal is directed by Academy Award-winning storyteller Spike Jonze and features actor Jesse Williams, best known for his longstanding activism and starring role in Grey’s Anatomy. The ad furthers MedMen’s vision where legalized and regulated cannabis creates a safer, healthier and happier world. Founded in 2010, MedMen is known for its disruptive advertising campaigns, innovative approach to cannabis retail and progressive legalization efforts.

The diverse creative team behind the project includes actor Jesse Williams, director Spike Jonze, Academy-Award nominated cinematographer Bradford Young and production designer James Chinlund, who is currently working on the upcoming Lion King movie.

MedMen launched a 360-degree approach to The New Normal campaign, which includes spots on connected TV networks (including Bravo, CBS Sports Network, Oxygen, MSNBC, Lifetime and Food Network), 80+ out of home assets, print ads (including national ad placements in Rolling Stone and US Weekly), Sirius XM, native integrations with Complex, podcasts and terrestrial radio, digital, pre-roll and programmatic ads. MedMen will also be advertising for the first time in hundreds of movie theaters across California, Nevada, and Michigan.

The commercial chronicles society’s evolving perceptions of the plant, from pre-prohibition to the modern industry of today. While looking back through America’s history, from George Washington’s hemp farm, to Reefer Madness propaganda, The New Normal takes the audience on a journey through the injustices of the past and a hopeful view for the future. Jonze and Williams collaborated to ensure that much of the commercial’s cast and crew had a personal real-life connection to the plant. Those individuals included military veterans who use cannabis to treat their PTSD, a former NFL football player who uses it as a substitute for opioids, victims of racial profiling and those who work in the emerging industry.

Jesse Williams, who also co-wrote the film with Jonze, will appear on the cover of EMBER volume 4, MedMen’s in-house magazine. The magazine will be free with purchase at every MedMen store beginning February 25, 2019. It will also be distributed at Barnes & Noble bookstores nationwide and select boutiques, hotels and restaurants.

In addition to the commercial, Spike Jonze is creating a short documentary with filmmaker Molly Schiot that was shot on set and explores the themes of the short film in more detail. It was important to all involved to tell the stories of cast members who all have their own relationships with cannabis, including: veterans who have found cannabis as a way to treat themselves, former law enforcement, formerly incarcerated drug offenders and young entrepreneurs in the cannabis industry.

All of this content as well as a brief history of cannabis and more is available on www.medmen.com.

Jesse Williams commented, “The highly selective criminalization of one plant, with flagrantly harsher punishments for one community, must be acknowledged and left behind for something more reasonable, realistic and fair. It’s pretty clear that Americans are ready to exist beyond a few inherited hypocrisies. We deserve the opportunity to make this right. We can do, and feel, better.”

When I read the premise about telling the story of the history of cannabis and our country, there was something that moved me about it. I apologize for using such a 2010’s word, but it felt healing to me. I didn’t know much about the specifics of the history, but as I learned about it, I felt like it was a story of a very dysfunctional couple. The relationship started in such a healthy place, with even our Founding Fathers having hemp farms, but it got so tragically messed up in the 80 years of prohibition that we couldn’t see straight. It was shocking to just sit in all the stories of so many people and so many lives that were unfairly hurt by the prohibition and the fear that was stoked by it, especially people of color. And it wasn’t just their lives, it was their families, too. And now we are starting to come out of it. We are at that point in a relationship where a couple is calming down after a fight and realizing how irrational they were and trying to make amends. I’ve never been into pot much or a huge advocate for legalization, but I’ve always supported it because it seemed absurd for the reasons we all know. And it always felt inevitable. But getting to do this, I got to learn the bigger picture of the whole story. I feel so hopeful, but the thing that sticks with me and upsets me is that there are still so many people that are still locked up for this plant that is now legal in so many places. That doesn’t make sense,” Spike Jonze stated.

“Cannabis is part of our country’s history. We’ve moved away from the propaganda of the past and into a world where cannabis is the new normal. We want this commercial to educate and embolden in equal measures. This is our opportunity to make a statement on a national stage,” said Adam Bierman, MedMen’s CEO & Co-Founder.

 

MedMen Signs Definitive Agreement For The Acquisition Of PharmaCann

CALIFORNIA: MedMen Enterprises and Chicago-based PharmaCann announce that they have entered into a definitive business combination agreement pursuant to which MedMen and PharmaCann will combine their respective businesses.

Under the Business Combination Agreement, a newly formed holding company (“New MedMen”) will acquire (a) all of the securities of PharmaCann in exchange for subordinate voting shares of New MedMen (the “New Class B Shares”) that are identical to the current Class B subordinate voting shares of MedMen, and (b) all of the Class B subordinate voting shares of MedMen in exchange for New Class B Shares on a one for one basis, pursuant to a plan of arrangement under the laws of British Columbia (the “Arrangement”). The securities to be issued in the Arrangement are intended to be eligible for exemption from the registration requirements under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), in accordance with Section 3(a)(10) thereof. In addition, all of the Class A super voting shares of MedMen will be acquired by New MedMen in exchange for super voting shares of New MedMen (“New Class A Shares”) on a one for one basis, pursuant to the Arrangement.

Under the terms of the Business Combination Agreement, PharmaCann securityholders will be issued New Class B Shares of New MedMen such that following the issuance, the former PharmaCann securityholders will hold approximately 25 percent of the fully-diluted equity of New MedMen (calculated using the treasury stock method), with the majority of such shares to be subject to lock up agreements for a period of 6 months or 12 months from the completion of the Transaction.

Following the completion of the Transaction, current holders of Class B subordinate voting shares of MedMen will hold that number of New Class B Shares equal to the number of Class B subordinate voting shares of MedMen held immediately prior thereto. The terms of the New Class B Shares will be substantively and economically identical to the current MedMen Class B Shares. The Transaction is structured to include an exchange of the current MedMen shares and a new holding company in order to facilitate the tax efficient acquisition of PharmaCann under United States tax laws. Other than the change in the legal entity that is the parent company, which will continue to be incorporated in British Columbia, there will be no change to the substantive or economic rights of the holders of the current Class B subordinate voting shares of MedMen or the current Class A super voting shares of MedMen, as compared to the result if PharmaCann had been directly acquired by MedMen. MedMen shareholders that hold share certificates will need to deliver such certificates for exchange following the closing. All other MedMen shareholders will receive their New MedMen shares without any action on their part.

MedMen Expands Its Presence in Arizona

Acquisition of Vertically-Integrated Operator Adds to MedMen’s Growing Footprint in One of the Top Medical Marijuana Markets in the U.S.

CALIFORNIA: MedMen Enterprises has announced that it has signed a definitive agreement to acquire control of Kannaboost Technology Inc. and CSI Solutions LLC, collectively referred to as “Level Up,” in a cash and stock transaction valued at $33,000,000. Level Up holds licenses for two vertically-integrated operations in Arizona, which include retail locations in Scottsdale and Tempe, as well as 25,000 square feet of cultivation and production capacity in Tempe and Phoenix. As part of the transaction, the Company will also receive a 40 percent stake in top-selling brand K.I.N.D. Concentrates (“K.I.N.D.”), which is currently distributed in over 90 percent of the dispensaries in Arizona.

medmenThis acquisition strengthens our presence in one of the top cannabis markets in the U.S.,” said Adam Bierman, MedMen chief executive and co-founder. “We will continue to identify highly accretive transactions in core states and remain laser focused on executing our retail playbook.”

Inclusive of Level Up and other pending acquisitions, MedMen’s footprint includes licenses for 69 retail stores and 17 cultivation and production facilities across 12 states.

In Arizona, the Company now controls three premier retail locations, 65,000 square feet in total cultivation and production capacity, and distribution and co-manufacturing rights for several top brands in Arizona, including K.I.N.D., Kiva, Mirth Provisions, HUXTON and Old Pal. The Company also has plans to introduce its [statemade] line of branded products to the Arizona market over the next 12 to 18 months.

“We have worked tremendously hard to build a company that puts the needs of patients in our local communities first,” said Michael Colburn, co-founder of Level Up. “This marks an exciting new chapter for our brands and for the medical marijuana patients who have supported us,” added Daryll DeSantis, Level Up co-founder.

MedMen Begins Trading On OTCQX Best Market

CALIFORNIA: MedMen Enterprises announced that it has qualified to trade on the OTCQX Best Market by OTC Markets Group under the ticker symbol MMNFF effective today.

The OTCQX market is reserved for established U.S. and global companies that meet high financial standards, provide timely news and disclosure to investors, and have a professional third-party sponsor introduction.

medmen

“MedMen’s step up to the OTCQX will expand our U.S. investor base and provide strong capital markets support to drive our continued growth,” said Adam Bierman, MedMen chief executive and co-founder. “The OTCQX market offers enhanced visibility and transparency, more efficient trading and increased liquidity for our investors. This is also reflective of the enormous progress we have made as an industry. U.S. cannabis companies are here to stay and we are creating jobs and wealth for generations to come.”

Today, MedMen has over 1,000 employees and operates 14 class-defining retail stores in the primary markets of California, Nevada and New York, in addition to cultivation and production factories in Nevada and New York. The Company recently signed a binding letter of intent to acquire PharmaCann, one of the largest medical cannabis providers in the U.S. Upon closing, the transaction brings the Company’s number of retail licenses to 67 and doubles the number of states where MedMen has operations to 12, including cultivation and manufacturing.

“Trading on the premium OTCQX Market will enable MedMen Enterprises to more efficiently provide their investors with current information and transparency,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “We are pleased to welcome MedMen Enterprises and look forward to supporting the company as it builds long-term shareholder value.”

MedMen Expands Footprint In Northern California With Acquisition Of San Jose Dispensary

CALIFORNIA: MedMen Enterprises announced that it has signed a definitive agreement to acquire Viktorya’s Medical Supplies LLC d/b/a Buddy’s Cannabis; a micro-business license entitling the Company to retail, distribute, cultivate and manufacture cannabis onsite in San Jose, California. This will be MedMen’s second retail store in Northern California.

“MedMen continues to expand its market share in California, the largest and most advanced cannabis market in the world,” said Adam Bierman, MedMen’s chief executive and co-founder. “Our next phase of growth will be focused on going deeper in the markets where we already have a presence and brand equity.”

The dispensary is a two-story building located in San Jose, the largest city in Northern California and the tenth most populous in the United States. This location will serve as the initial hub for the Company’s Northern California platform. San Jose resides in the booming Silicon Valley, home to hundreds of start-ups and global technology companies.

Since becoming a public company in May 2018, MedMen has executed on its stated acquisition strategy. Including pending acquisitions, MedMen now has licenses for 67 retail stores and 14 cultivation and production facilities across the US.

The all-cash transaction is expected to close within 90 days of signing and is subject to customary closing conditions and regulatory approvals.

MedMen Real Estate Assets Seed New Investment Vehicle

CALIFORNIA: MedMen Enterprises announced that it has reached agreement to sell a significant portion of its real estate assets to the newly formed Treehouse Real Estate Investment Trust (“Treehouse”). Treehouse is a real estate investment vehicle that capitalizes on the cannabis industry’s continued growth; initial investors include real estate firms New England Development, Samuels & Associates and Visconsi Companies, in partnership with Stable Road Capital.

medmen

The initial transaction includes three properties and is expected to generate approximately $12.5 million of proceeds to the Company after repayment of debt. Additional real estate assets in MedMen’s portfolio are expected to be sold to Treehouse over the next 12 months. The properties sold to Treehouse will be leased backed to MedMen or its subsidiaries at market rates under long-term leases.

“MedMen owns and controls some of the best real estate in today’s burgeoning cannabis industry and they will serve as an important seed portfolio for Treehouse,” said Brian Kabot, chief investment officer of Stable Road. “Given the investor interest in the sector, this vehicle made a lot of sense. More importantly, this creates liquidity and creates an efficient form of off-balance sheet financing to foster further growth for MedMen and others in the industry who wish to grow.”

“Thoughtful property owners across the country have begun to consider the role that cannabis retailers play in their overall leasing strategy, putting Treehouse at the vanguard of an emerging business opportunity,” commented Scott Baker of New England Development. “Many cannabis operators own prime parcels in highly sought after communities, offering a variety of opportunities for return on investment and future development.”

The three initial properties included in the transaction are:

  • MedMen Abbot Kinney – the only cannabis store in what GQ calls the “Coolest Block in America,” 1308-1312 Abbot Kinney Blvd., Venice, California.
  • MedMen Beverly Hills – the store is in a bustling shopping district adjacent to the city of Beverly Hills, 106-110 S. Robertson Blvd., Los Angeles, California.
  • MedMen Downtown Las Vegas – the Company’s first branded store in Las Vegas in the heart of the city’s Arts District and near the Fremont Street Experience, 823 S. 3rd Street, Las Vegas, Nevada.

MedMen Doubles Market Reach With Acquisition Of PharmaCann

CALIFORNIA: MedMen Enterprises Inc. and Chicago-based PharmaCann have signed a binding letter of intent for MedMen to acquire PharmaCann in an all-stock transaction valued at $682 million.

The resulting pro-forma company (including pending acquisitions by MedMen) will have a portfolio of cannabis licenses in 12 states that will permit the combined company to operate 79 cannabis facilities. The combined company will operate in 12 states, which comprise a total estimated addressable market, as of 2030, of approximately $40 billion according to Cowen Group. Through the transaction, MedMen will add licenses in Illinois, New York, Pennsylvania, Maryland, Massachusetts, Ohio, Virginia and Michigan.

medmen“This is a transformative acquisition that will create the largest U.S. cannabis company in the world’s largest cannabis market,” said Adam Bierman, MedMen’s chief executive officer and co-founder. “The transaction adds tremendous scale to our vertically integrated business model by expanding our U.S. retail footprint across important growth markets while strengthening our cultivation and production capabilities. With the revenue synergies that the deal is expected to produce, MedMen is well positioned to continue executing on our growth strategy. This would not have been possible even two years ago and is a testament to how far both the industry and these two companies have evolved. PharmaCann’s leadership has built a world-class organization, and we are excited about the value this transaction is creating for shareholders.”

Founded in 2014, PharmaCann is one of the largest medical cannabis providers in the U.S. It currently operates 10 retail stores and three cultivation and production facilities across multiple states, including New York, Maryland and Massachusetts, and in Illinois, where it is the largest holder of medical cannabis licenses. The company also owns licenses for retail stores in Pennsylvania, Maryland, Massachusetts, Ohio, Virginia and Michigan, and cultivation and production licenses in all of its markets, excluding Maryland. PharmaCann is known for its high-quality cultivation and production and has one of the best track records in the industry for cannabis license applications.

“PharmaCann has built highly-efficient cultivation centers and dispensaries to promote a better quality of life for medical marijuana patients,” said Teddy Scott, Ph. D., PharmaCann chief executive officer. “This acquisition validates the dedication and level of sophistication we have used to provide consistent patient outcomes. I am proudest of the top-notch team we have assembled here and their dedication to our mission of serving medical marijuana patients. Our organization is a natural fit for MedMen, and we are excited to join a leading enterprise with a best-in-class management team.”

MedMen currently operates 14 retail stores in the primary markets of California, Nevada and New York. The Company recently acquired a license to open and operate 30 retail stores in Florida and has signed binding agreements to acquire an operating retail store in Illinois, cultivation and retail operations in Arizona, and an additional non-operating retail license in California. The Company has cultivation and production facilities in Nevada and New York, and is building facilities in Desert Hot Springs, California and outside Orlando, Florida. PharmaCann is licensed for 18 retail stores in eight states and eight cultivation and production facilities in seven states. Combined, the two companies will be licensed for 66 retail stores and 13 cultivation and production facilities (including pending acquisitions by MedMen).

MedMen Acquires First Dispensary In San Francisco Bay Area

CALIFORNIA: MedMen Enterprises announced that it has signed a definitive agreement to acquire a licensed dispensary from Berkeley Patients Group in Emeryville, California. As a result of the transaction, MedMen will have one of only two adult-use licenses issued in the City of Emeryville, just outside San Francisco.

medmen

The dispensary is located in a young professional hub of the East Bay, between Oakland and Berkeley. The City of Emeryville is home to the national headquarters of numerous corporations including Pixar Animation Studios, Peet’s Coffee & Tea, Jamba Juice and Cliff Bar. The store is expected to open in 2019 and will be located at 3996 San Pablo Avenue, across the street from the Bay Street Emeryville Shopping Center, which features more than 50 businesses with over 450,000 square feet of retail space.

“California is the world’s largest legal cannabis market,” said Adam Bierman, MedMen chief executive and co-founder. “We are very proud of the footprint we’ve already established in our home state and look forward to expanding our reach to all corners of the Golden State, starting with our first store in Northern California.”

MedMen, based in Los Angeles, currently operates eight dispensaries in Southern California. The Emeryville dispensary is located in the commercial heart of the East Bay. It is positioned at the intersection of three major interstate highways that see over 600,000 daily commuters from Oakland, Berkeley, San Francisco and other cities.

As consideration for the acquisition, the Company will pay a combination of cash at closing and shares of MedMen Enterprises, Inc. in an undisclosed amount*. The transaction is expected to close within 90 days of signing and is subject to customary closing conditions.